| P2093 | author name string | Arun K Seth | |
| | Q Ping Dou | |
| | Daniela Buac | |
| | Fathima R Kona | |
| P2860 | cites work | Therapeutic metformin/AMPK activation promotes the angiogenic phenotype in the ERalpha negative MDA-MB-435 breast cancer model | Q37023195 |
| | Standards of medical care in diabetes--2009. | Q37036416 |
| | Transcriptional activation of breast cancer-associated gene 2 by estrogen receptor | Q37137658 |
| | AMP-activated protein kinase in skeletal muscle: from structure and localization to its role as a master regulator of cellular metabolism | Q37276696 |
| | AMP-activated protein kinase promotes human prostate cancer cell growth and survival | Q37415957 |
| | AMP-activated protein kinase: new regulation, new roles? | Q38019034 |
| | HER2-targeted therapy in breast cancer: a systematic review of neoadjuvant trials | Q38083982 |
| | AMPK activation by oncogenesis is required to maintain cancer cell proliferation in astrocytic tumors | Q39201386 |
| | AMPK-induced activation of Akt by AICAR is mediated by IGF-1R dependent and independent mechanisms in acute lymphoblastic leukemia | Q39652396 |
| | Metformin and rapamycin have distinct effects on the AKT pathway and proliferation in breast cancer cells | Q39743196 |
| | The active form of the metabolic sensor: AMP-activated protein kinase (AMPK) directly binds the mitotic apparatus and travels from centrosomes to the spindle midzone during mitosis and cytokinesis. | Q39832963 |
| | AMPK exerts dual regulatory effects on the PI3K pathway. | Q39861564 |
| | Effect of different doses of metformin on serum testosterone and insulin in non-diabetic women with breast cancer: a randomized study. | Q42506632 |
| | Insulin-lowering effects of metformin in women with early breast cancer | Q46202863 |
| | Berberine and its more biologically available derivative, dihydroberberine, inhibit mitochondrial respiratory complex I: a mechanism for the action of berberine to activate AMP-activated protein kinase and improve insulin action | Q46745033 |
| | Evidence for biological effects of metformin in operable breast cancer: a pre-operative, window-of-opportunity, randomized trial. | Q54583667 |
| | Location and function of three sites phosphorylated on rat acetyl-CoA carboxylase by the AMP-activated protein kinase | Q68082700 |
| | The substrate and sequence specificity of the AMP-activated protein kinase. Phosphorylation of glycogen synthase and phosphorylase kinase | Q69370621 |
| | Complexes between the LKB1 tumor suppressor, STRAD alpha/beta and MO25 alpha/beta are upstream kinases in the AMP-activated protein kinase cascade | Q21245891 |
| | A novel RING-type ubiquitin ligase breast cancer-associated gene 2 correlates with outcome in invasive breast cancer | Q24294937 |
| | Novel RING E3 ubiquitin ligases in breast cancer | Q24300517 |
| | Downregulation of AMP-activated protein kinase by Cidea-mediated ubiquitination and degradation in brown adipose tissue | Q24312853 |
| | Autoubiquitination of BCA2 RING E3 ligase regulates its own stability and affects cell migration | Q24316451 |
| | Investigating metformin for cancer prevention and treatment: the end of the beginning | Q26863783 |
| | Metformin in cancer: translational challenges | Q26866388 |
| | Control of AMPK-related kinases by USP9X and atypical Lys(29)/Lys(33)-linked polyubiquitin chains | Q28267528 |
| | Characterization of the AMP-activated protein kinase kinase from rat liver and identification of threonine 172 as the major site at which it phosphorylates AMP-activated protein kinase | Q28296225 |
| | Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain | Q29615210 |
| | Metformin and reduced risk of cancer in diabetic patients | Q29616275 |
| | The LKB1-AMPK pathway: metabolism and growth control in tumour suppression | Q29617506 |
| | 5-aminoimidazole-4-carboxamide ribonucleoside. A specific method for activating AMP-activated protein kinase in intact cells? | Q29618095 |
| | Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group | Q29619251 |
| | BCA2/Rabring7 promotes tetherin-dependent HIV-1 restriction | Q33519521 |
| | Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis. | Q33718914 |
| | The ubiquitin-mediated proteolytic pathway: mode of action and clinical implications | Q33890102 |
| | Effects of partner proteins on BCA2 RING ligase activity | Q34153494 |
| | Tamoxifen: a most unlikely pioneering medicine | Q34180688 |
| | Therapeutic anti-cancer targets upstream of the proteasome. | Q34195702 |
| | Role of the BCA2 ubiquitin E3 ligase in hormone responsive breast cancer | Q34416164 |
| | AMPK and Akt determine apoptotic cell death following perturbations of one-carbon metabolism by regulating ER stress in acute lymphoblastic leukemia | Q34647789 |
| | Regulation of AMPK by the ubiquitin proteasome system | Q34756301 |
| | The ubiquitin-proteasome system as a prospective molecular target for cancer treatment and prevention | Q35836872 |
| | Cytotoxic effect of 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside (AICAR) on childhood acute lymphoblastic leukemia (ALL) cells: implication for targeted therapy | Q35940027 |
| | Cellular responses to the metal-binding properties of metformin. | Q35976604 |
| | AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stress | Q36713683 |
| | From bortezomib to other inhibitors of the proteasome and beyond | Q36852277 |
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 12 | |
| P921 | main subject | metformin | Q19484 |
| | breast cancer | Q128581 |
| P304 | page(s) | 1379-1390 | |
| P577 | publication date | 2013-12-01 | |
| P1433 | published in | Neoplasia | Q2962042 |
| P1476 | title | Regulation of metformin response by breast cancer associated gene 2. | |
| P478 | volume | 15 | |